Provided by Tiger Trade Technology Pte. Ltd.

INCANNEX HEALTHCARE LTD

3.21
-0.0400-1.23%
Post-market: 3.220.0125+0.39%19:58 EDT
Volume:58.21K
Turnover:189.91K
Market Cap:40.27M
PE:-1.94
High:3.33
Open:3.32
Low:3.20
Close:3.25
52wk High:15.00
52wk Low:2.49
Shares:12.54M
Float Shares:10.18M
Volume Ratio:0.73
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6556
EPS(LYR):-40.8237
ROE:-47.80%
ROA:-24.58%
PB:0.60
PE(LYR):-0.08

Loading ...

Incannex Healthcare Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Sep 28

Incannex Net Loss Narrows 59% to $19.3 Million in FY26; Revenue Falls to no Revenue

Reuters
·
Sep 25

Incannex Healthcare Inc Expected to Post a Loss of 75 Cents a Share - Earnings Preview

Reuters
·
Sep 25

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position

THOMSON REUTERS
·
Sep 09

Incannex Wins US Patent for IHL-42X Obstructive Sleep Apnea Treatment, Expiry 2040

Reuters
·
Sep 09

Incannex doses first patient in DReAMzz study of IHL-42X

TIPRANKS
·
Aug 25

Incannex Announces First Patient Dosed in Dreamzz Phase 2 Study of Ihl-42X

THOMSON REUTERS
·
Aug 25

Incannex Doses First Patient in Phase 2 DReAMzz Trial of IHL-42X for Sleep Apnea

Reuters
·
Aug 25

Incannex Receives Additional A$5.1 Million Research and Development Tax Incentive Refund

Reuters
·
Aug 11

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More than A$11.2 Million in Non-Dilutive Capital Received in 2026

THOMSON REUTERS
·
Aug 11

Incannex Wins Approval of Overseas Findings, Secures A$5.1 Million R&D Tax Refund

Reuters
·
Aug 11

Incannex Healthcare - Receives Final A$5.1 Mln R&D Tax Incentive Refund for FY25 - SEC Filing

THOMSON REUTERS
·
Aug 11

Incannex Commences Participant Screening in Dreamzz Phase 2 Study of Ihl-42x for Obstructive Sleep Apnea

THOMSON REUTERS
·
Jul 23

Incannex Healthcare Announces Press Release Availability

Reuters
·
Jul 23

Incannex Starts Screening Patients in Phase 2 Dreamzz Trial of Ihl-42x for Sleep Apnea

Reuters
·
Jul 23

Incannex granted IHL-42X composition patent by USPTO

TIPRANKS
·
Jun 25

Incannex Healthcare - Granted U.S. Patent for Ihl-42x in Obstructive Sleep Apnoea - SEC Filing

THOMSON REUTERS
·
Jun 25

Incannex Wins US Patent for Ihl-42x Obstructive Sleep Apnea Therapy

Reuters
·
Jun 25

Press Release: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility

Dow Jones
·
Jun 10

Incannex Healthcare - Receives a$6 Mln R&D Tax Incentive Refund for FY25 - SEC Filing

THOMSON REUTERS
·
Jun 10